Randomized controlled trial to evaluate the efficacy of per-protocol administration of Methylprednisolone compared to Dexamethasone in SARS-CoV-2 infections requiring respiratory support. : Randomized controlled trial of methylprednisolone versus dexamethasone in COVID-19 pneumonia - Methylprednisolone Vs dexamethasone in COVID-19

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 26. Juli To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [Kostenfrei]

Keywords:

610
Medical Condition: Hospitalized patients with COVID-19 requiring respiratory support MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Phase: Phase 3
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 22-03-2021, Last updated: 2021-07-30

PPN (Catalogue-ID):

WHO007781849